GPX4 and hepatocellular carcinoma: In terms of RSL3 sensitivity, NDI1 expression significantly right-shifted the dose response of NCI-HCC cells, suggesting that restoration of mitochondrial complex I activity augmented resistance to GPX4 inhibition (Fig. 7D).